GSK Unveils Two-Year Plan For Consumer Split

GSK preparing to seize “a major opportunity to create a new leader in consumer health” with two-year program which will see the company split in two and create the world's biggest standalone OTC player.

GlaxoSmithKline
• Source: Shutterstock

GlaxoSmithKline PLC has set out concrete plans for creating the world’s largest standalone consumer healthcare company by 2022.

More from Strategy

More from Business